Phase 2 Study of Pembrolizumab Combined With Chemoradiation Therapy in Anaplastic Thyroid Cancer
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Pembrolizumab (Primary) ; Docetaxel; Doxorubicin; Ropidoxuridine
- Indications Carcinoma; Thyroid cancer
- Focus Therapeutic Use
- 16 Mar 2020 Status changed from active, no longer recruiting to completed.
- 29 Jan 2020 Planned End Date changed from 9 Dec 2019 to 9 Dec 2020.
- 27 Apr 2018 Status changed from suspended to active, no longer recruiting.